Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2002
11/20/2002CN1380317A A polypeptide-ribosomal protein SII-11.99 and polynucleotide for coding this polypeptide
11/20/2002CN1380316A A polypeptide-transducin subunit-15.84 and polynucleotide for coding this polypeptide
11/20/2002CN1380315A A polypeptide-phytochrome protein-9.35 and polynucleotide for coding this polypeptide
11/20/2002CN1380314A A polypeptide-guanine deoxynucleosidase activator protien-13.20 and polynucleotide for coding this polypeptide
11/20/2002CN1380313A A polypeptide-ZP1 receptor protein -37.95 and polynucleotide for coding this polypeptide
11/20/2002CN1380312A A polypeptide-acidic secretion protein-9.35 and polynucleotide for coiding this polypeptide
11/20/2002CN1380311A A polypeptide-histone H3-9.35 and polynucleotide for coding this polypeptide
11/20/2002CN1380310A A polypeptide-ring finger protein-24.20 and polynucleotide for coding this polypeptide
11/20/2002CN1380309A A polypeptide-high mobility component protein familia-11.44 and polynucleotide for coding this polypeptide
11/20/2002CN1380308A A polypeptide-gap junction protein-12.21 and polynucleotide for coding this polypeptide
11/20/2002CN1380307A A polypeptide-ribosomal protein -9.57 and polynucleotide for coding said polypeptide
11/20/2002CN1380306A A polypeptide-uteroglobin-10.02 and polynucleotide for coding this polypeptide
11/20/2002CN1380305A A polypeptide-air bubble protein -9.02 and polynucleotide for coding this polypeptide
11/20/2002CN1380304A N-terminal deletion lipocyte complement related protein and its preparation method
11/20/2002CN1380303A A novel polypeptide-human retinoblastoma binding protein 34.54 and polynucleotide for coding this polypeptide
11/20/2002CN1379989A Glycooxidase and its application in baking process
11/19/2002US6484127 Oil maintenance indicator
11/19/2002US6483012 Methods for producing parthenocarpic or female sterile transgenic plants and methods for enhancing fruit setting and development
11/19/2002US6483010 DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules
11/19/2002US6482937 Porcine Oct-4 promoter
11/19/2002US6482936 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/19/2002US6482934 Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells
11/19/2002US6482933 Molecules of the card-related protein family and uses thereof
11/19/2002US6482929 Antibodies to ARF-p19
11/19/2002US6482928 Fab′-epitope complex from HIV-1 cross-neutralizing monoclonal antibody 2F5
11/19/2002US6482927 Chimeric proteins comprising the extracellular domain of murine Ob receptor
11/19/2002US6482925 Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants
11/19/2002US6482924 Leptospira vaccine antigens for the prevention of Leptospirosis
11/19/2002US6482923 Interleukin 17-like receptor protein
11/19/2002US6482922 Mammary transforming protein
11/19/2002US6482919 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
11/19/2002US6482860 Pentafluorobenzenesulfonamides and analogs
11/19/2002US6482803 Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A
11/19/2002US6482798 Aprotinin variants having a net charge of +3 to -3 at ph 7 and with the amino acids arg15 or arg15-ala17 in the binding region; serine protease inhibitor
11/19/2002US6482795 Tumor suppressor designated TS10q23.3
11/19/2002US6482646 Plant proteins that interact with nuclear matrix proteins and function as transcriptional activators
11/19/2002US6482636 Constructed Bacillus thuringiensis strains producing mosquitocidal crystal proteins
11/19/2002US6482633 Accessory functions for use in recombinant AAV virion production
11/19/2002US6482621 Compositions and methods for fumonisin detoxification
11/19/2002US6482617 Viable contaminant particle free adenoviruses, their preparation and use
11/19/2002US6482616 RCA-free adenoviral vector system and propagation method
11/19/2002US6482614 Stress proteins and uses therefor
11/19/2002US6482613 Microbial production of mature human leukocyte interferons
11/19/2002US6482612 Adipocyte-specific protein homologs
11/19/2002US6482611 Human capsaicin receptor and uses thereof
11/19/2002US6482609 Isolated human EDG-4 receptor and polynucletide encoding said receptor
11/19/2002US6482608 Cloning and recombinant production of CRF receptor(S)
11/19/2002US6482607 Expression vector for use in a one-step purification protocol
11/19/2002US6482606 Human DNA mismatch repair polynucleotides
11/19/2002US6482605 Protein tyrosine phosphatase PTP20 and related products and methods
11/19/2002US6482598 Antibody recognizing a small subset of human hematopoietic cells
11/19/2002US6482597 Compounds and methods for therapy and diagnosis of lung cancer
11/19/2002US6482594 Made by exposing nucleic acid candidate sequences having photoreactive groups to the target molecule, irradiating complexes formed to crosslink, and separating the crosslinked complexes and amplifying to give the ligands
11/19/2002US6482587 Methods to inhibit or enhance the binding of viral DNA to genomic host DNA
11/19/2002US6482586 Hybrid compositions for intracellular targeting
11/19/2002US6482416 Alteration of macrophage-induced t cell suppression or concentration by the selective elimination or increase of tryptophan by administering an enzyme inhibitor of indole-amino 2,3-deoxygenase; viricides; abortion; fertility;
11/19/2002US6482415 Expression and refolding of truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi and its use in antibody based detection assays and vaccines
11/19/2002US6482414 Cold-adapted equine influenza viruses
11/19/2002US6482412 Actinomyces used to biosynthesize polypeptide to treat aids
11/19/2002US6482411 Osteoporosis
11/19/2002US6482410 Mediation of neuronal attachment and enhancement of the outgrowth of neutites
11/19/2002US6482409 Treatment for inflammatory bowel disease with a vcam-1/1gG fusion protein
11/19/2002US6482408 Fibroblast growth factor 15 antibodies
11/19/2002US6482407 Membrane-bound cytokine compositions comprising GM-CSF or an active fragment thereof and methods of modulating and an immune response using the same
11/19/2002US6482404 Transplantation of tissue comprising a DNA sequence encoding a homologous complement restriction factor
11/19/2002US6482403 Caniney IL-13 immunoregulatory proteins and uses thereof
11/19/2002US6481065 Jewelry closure
11/19/2002CA2312667C Novel cytokine
11/19/2002CA2261579C Isolated peptides derived from mage-2
11/19/2002CA2091700C A non-mitogenic competitive hgf antagonist
11/19/2002CA2063580C Receptor assay for fk-506
11/19/2002CA2040793C Plasmids expressing patatin and adp-glucose-pyrophosphorylase sequences
11/19/2002CA1341399C Intercellular adhesion molecules and their binding ligands
11/19/2002CA1341398C Expression of biologically active pdgf analogs in eucaryotic cells
11/16/2002CA2383556A1 High-efficiency assay for protein mannosyl transferases
11/16/2002CA2382977A1 Plasmodium falciparum antigens and their vaccinal and diagnostic applications
11/14/2002WO2002092769A2 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/14/2002WO2002090991A2 Proteins and genes for diagnosis and treatment of erbb2-related cancer
11/14/2002WO2002090986A1 Colon cancer antigen panel
11/14/2002WO2002090985A1 Peptide-immobilized baseboard and method of assaying target protein using the same
11/14/2002WO2002090981A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof
11/14/2002WO2002090974A2 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
11/14/2002WO2002090926A2 Dose response-based methods for identifying receptors having alterations in signaling
11/14/2002WO2002090925A2 Polypeptides and nucleic acids associated with cancer
11/14/2002WO2002090924A2 Mutation induced optimization of receptor signal to noise ratio
11/14/2002WO2002090600A2 A method for regulating immune function in primates using the foxp3 protein
11/14/2002WO2002090595A1 Methods for modulating an immune response by modulating krc activity
11/14/2002WO2002090568A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/14/2002WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002WO2002090557A2 Freeze-tolerant eukaryotic cells
11/14/2002WO2002090556A1 Method for targeted homologous gene replacement in kinetoplastidae
11/14/2002WO2002090553A2 Recombinant fusion proteins and the trimers thereof
11/14/2002WO2002090550A2 Method for preparing recombinant poxvirus
11/14/2002WO2002090549A2 Compositions and methods for the modulation of viral maturation
11/14/2002WO2002090548A1 Method of purifying chromosomal dna replication initiating protein dnaa of pathogenic bacterium using affinity of dnaa protein for atp, method of evaluating antibacterial activity and method of screening compound having antibacterial activity using affinity of dnaa protein for atp
11/14/2002WO2002090547A1 Modification of plant and seed development and plant responses to stresses and stimuli
11/14/2002WO2002090546A1 Polypeptide serving as angiogenic marker and dna thereof
11/14/2002WO2002090545A2 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide
11/14/2002WO2002090544A2 Protein-protein interactions in adipocyte cells (3)
11/14/2002WO2002090542A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof